1 / 13

Key information in informed consent documents

This presentation provides key information on informed consent documents, including the revised Common Rule, basic responsibilities of researchers and IRBs, and guidelines for organizing and presenting information effectively. Developed by U-MIC.

saltz
Download Presentation

Key information in informed consent documents

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. To start the presentation, click on this button in the lower right corner of your screen. The presentation will begin after the screen changes and you press enter. Developed by: U-MIC

  2. Key information in informed consent documents Revised Common Rule Developed by: U-MIC University of Michigan IRB Collaborative

  3. Common Rule • 45 CFR 46 subpart A • basic responsibilities • researchers • IRBs • informed consent • 2018 revised Common Rule • effective January 21, 2019 • key information • beginning of document Key information in informed consent documents Developed by: U-MIC

  4. Revised Common Rule • 45 CFR 46.116(a)(5)(i) • Informed consent must begin with a concise and focused presentation of the key information that is most likely to assist a prospective subject or legally authorized representative in understanding the reasons why one might or might not want to participate in the research. This part of the informed consent must be organized and presented in a way that facilitates comprehension. • 45 CFR 46.116(a)(5)(ii) • Informed consent as a whole must present information in sufficient detail relating to the research, and must be organized and presented in a way that does not merely provide lists of isolated facts, but rather facilitates the prospective subject’s or legally authorized representative’s understanding of the reasons why one might or might not want to participate. Key information in informed consent documents Developed by: U-MIC

  5. Revised Common Rule • reasonable person standard • hypothetical average person • particular nature of the study • Key information should accommodate to concerns of subject population. • researchers developing consent materials • IRBs reviewing research Key information in informed consent documents Developed by: U-MIC

  6. Considerations for reviewing the key study information section of an informed consent document • IRBMED’s standard informed consent template • designed to comply with revised Common Rule • including the key information requirement • HHS: key information requirement usually satisfied by five elements • consent sought for research, participation voluntary • purposeof research, duration of participation, study procedures • risks • benefits • alternatives Key information in informed consent documents Developed by: U-MIC

  7. Considerations for reviewing the key study information section of an informed consent document • key information section • voluntariness • research • differs from clinical care • study purpose • blue boxes contain prepared language pertaining to common types of research • drug/device studies • behavioral interventions • data/biospecimen collection • definitions • randomization • washout • IRB confirms accuracy/conciseness of study purpose summary. Key information in informed consent documents Developed by: U-MIC

  8. Considerations for reviewing the key study information section of an informed consent document • risks • sample risk language • designed to • orient potential subjects to study • highlight significant risks • Risk language taken from elsewhere in document may not be adequate. • IRB assesses appropriateness of risk summary. • whether most common or serious • whether general statement preferable to list of risks • “Participation in this study involves serious risks, some of which could be painful, require hospitalization, or be life-threatening.” Key information in informed consent documents Developed by: U-MIC

  9. Considerations for reviewing the key study information section of an informed consent document • benefits • General statement may suffice. • IRB confirms consistency with benefits section. • direct • indirect Key information in informed consent documents Developed by: U-MIC

  10. Considerations for reviewing the key study information section of an informed consent document • duration of study participation • alternatives to taking part • IRB ensures consistency with remainder of document. Key information in informed consent documents Developed by: U-MIC

  11. Key information section does not • supplant complete consent process • opportunity to discuss and consider participation • satisfy all informed consent requirements Key information in informed consent documents Developed by: U-MIC

  12. Key information in informed consent documents Key information ininformed consent documents Developed by: U-MIC

  13. Ray-Nitra Reynolds Brian Seabolt IRBMED Thank you. Developed by: U-MIC

More Related